Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
24.18
+1.44 (6.33%)
Mar 6, 2026, 4:08 PM HKT
Market Cap11.05B
Revenue (ttm)61.85M
Net Income-243.14M
EPS-0.58
Shares Out456.82M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume775,200
Average Volume590,200
Open22.28
Previous Close22.74
Day's Range22.28 - 24.56
52-Week Range21.36 - 74.00
Betan/a
RSI36.12
Earnings DateMay 6, 2026

About HKG:2591

Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in the development of drugs. The company’s products are used for the treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 105
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2591
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements